Matthew S. McIlwain
Director · Nautilus Biotechnology, Inc.
Individual
- 2026
- Jun 22, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Matthew S. McIlwain files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- AH Equity Partners Bio II, L.L.C. - $11.75M in NAUT purchases and sales in the last 12 months
- Kentaro Suzuki - $6K in NAUT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Matthew S. McIlwain?
Matthew S. McIlwain is a corporate insider, tracked as Director of Nautilus Biotechnology, Inc. (NAUT). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Matthew S. McIlwain last file a Form 4?
The only primary Form 4 on record is dated 22 June 2026.